tiprankstipranks
Trending News
More News >
Nissan Chemical Corporation (JP:4021)
:4021

Nissan Chemical (4021) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4021

Nissan Chemical

(4021)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 5.2)
Rating:75Outperform
Price Target:
¥7,728.00
▲(48.96% Upside)
The score is driven primarily by strong financial performance (high margins, low leverage, attractive ROE) and a reasonable valuation with a ~3% dividend. The main offset is technicals: the trend is strong, but RSI/Stoch are extremely overbought, increasing near-term pullback risk.
Positive Factors
High Profitability
Sustained high margins indicate durable product differentiation and pricing power in specialty chemicals. Such profitability supports reinvestment in R&D and capacity, funds dividends and buybacks, and cushions returns through cycles, underpinning long-term earnings quality and ROE.
Conservative Balance Sheet
Very low leverage provides financial flexibility to fund capex, M&A or shareholder returns and to withstand cyclical downturns. A strong equity base reduces refinancing risk and supports stable capital allocation over the next several quarters to years.
Strong Free Cash Flow
Healthy FCF generation and a high FCF-to-net-income ratio indicate earnings convert to cash at a meaningful rate, enabling consistent funding of operations, investment in specialty product development, and steady shareholder returns even with modest revenue growth.
Negative Factors
Modest Top-line Growth
Low-single-digit organic growth constrains long-term upside and means returns must come mainly from margins, cost control, or capital allocation. In specialty chemicals, sustained low growth increases reliance on cyclical end-market recoveries or successful new product commercialization.
Volatile Cash Conversion
Intermittent gaps between reported earnings and operating cash suggest working-capital timing or collection risks. Persistent volatility in cash conversion can constrain reinvestment, limit flexibility in downturns, and raise execution risk for long-duration projects or payout commitments.
Exposure to Cyclical End-Markets
Significant exposure to agriculture and electronics links revenue to seasonal, regulatory, and capital-spending cycles. These end-market cyclicities can produce uneven demand, lengthen product qualification timelines, and increase sensitivity of growth and margins to macro trends over the medium term.

Nissan Chemical (4021) vs. iShares MSCI Japan ETF (EWJ)

Nissan Chemical Business Overview & Revenue Model

Company DescriptionNissan Chemical Corporation (4021) is a Japanese chemical company that operates primarily in the fields of specialty chemicals, agricultural chemicals, and electronic materials. The company develops and manufactures a wide range of products, including agrochemicals, electronic materials for semiconductors, and other specialty chemicals that cater to various industries. With a focus on innovation and sustainability, Nissan Chemical aims to provide high-quality solutions that meet the evolving needs of its customers across different sectors.
How the Company Makes MoneyNissan Chemical generates revenue through several key streams, primarily from the sale of its specialty chemicals and agricultural products. The company’s agrochemical division, which includes herbicides, insecticides, and fungicides, contributes significantly to its earnings by serving the agricultural sector. Additionally, its electronic materials segment, which produces materials for semiconductor manufacturing and displays, has seen growth due to the increasing demand for electronics. Strategic partnerships with other companies in the tech and agricultural fields also enhance Nissan Chemical's market reach and bolster its revenue. The company emphasizes R&D to innovate new products, which can lead to increased sales and market share, further contributing to its financial performance.

Nissan Chemical Financial Statement Overview

Summary
Overall financials are strong: high profitability (TTM gross margin ~46%, operating ~23%, net ~17%), conservative leverage (TTM D/E ~0.17) and solid ROE (~19.5%). Free cash flow is healthy (~¥46B) with ~73% FCF-to-net-income, but cash conversion has been somewhat volatile historically and growth is modest.
Income Statement
83
Very Positive
Profitability is strong for a chemicals company, with TTM (Trailing-Twelve-Months) gross margin ~46%, operating margin ~23%, and net margin ~17%. Earnings power looks resilient and consistent over the period, and revenue has re-accelerated from roughly flat in FY2024 to low-single-digit growth in TTM. The main offset is that the growth profile is modest and margins have eased slightly from the peak levels seen in FY2022–FY2023.
Balance Sheet
88
Very Positive
The balance sheet is conservatively positioned with low leverage (TTM debt-to-equity ~0.17) and a sizeable equity base. Returns to shareholders are attractive (TTM return on equity ~19.5%) and have generally improved versus prior years, suggesting efficient capital use. A watch item is that leverage has ticked up from earlier years (FY2022–FY2023), though it remains very manageable.
Cash Flow
78
Positive
Cash generation is solid in TTM (Trailing-Twelve-Months), with free cash flow of ~¥46B and improving versus FY2024’s weaker conversion year. Free cash flow equals ~73% of net income in TTM, indicating generally good earnings quality, but cash conversion has been somewhat volatile historically (notably weaker in FY2023–FY2024). Operating cash flow relative to reported earnings is also below 1.0 in TTM, implying working-capital or timing effects that can create periodic fluctuations.
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue271.97B251.37B226.71B228.06B207.97B209.12B
Gross Profit126.17B116.54B104.78B106.80B101.09B87.75B
EBITDA77.54B74.55B66.11B67.84B64.45B55.97B
Net Income46.38B43.04B38.03B41.09B38.78B33.47B
Balance Sheet
Total Assets340.14B330.76B323.46B298.71B279.69B265.51B
Cash, Cash Equivalents and Short-Term Investments34.04B27.45B22.74B29.65B34.66B32.38B
Total Debt40.95B40.47B40.98B27.29B22.71B22.67B
Total Liabilities94.60B94.58B92.56B77.19B71.68B64.95B
Stockholders Equity241.84B233.29B227.47B218.42B205.91B198.83B
Cash Flow
Free Cash Flow46.41B43.01B12.70B15.05B29.10B30.40B
Operating Cash Flow63.66B59.18B33.70B35.23B41.95B39.94B
Investing Cash Flow-19.60B-17.61B-18.74B-19.64B-12.39B-12.85B
Financing Cash Flow-39.75B-35.65B-22.10B-25.03B-27.87B-25.63B

Nissan Chemical Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5188.00
Price Trends
50DMA
5667.54
Positive
100DMA
5446.72
Positive
200DMA
5066.57
Positive
Market Momentum
MACD
340.37
Negative
RSI
67.11
Neutral
STOCH
76.18
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4021, the sentiment is Positive. The current price of 5188 is below the 20-day moving average (MA) of 6028.90, below the 50-day MA of 5667.54, and above the 200-day MA of 5066.57, indicating a bullish trend. The MACD of 340.37 indicates Negative momentum. The RSI at 67.11 is Neutral, neither overbought nor oversold. The STOCH value of 76.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4021.

Nissan Chemical Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥894.13B19.3219.69%3.15%10.06%18.03%
75
Outperform
¥10.96T21.7010.87%2.17%3.77%0.35%
68
Neutral
¥844.69B24.654.79%4.21%-1.21%-27.21%
66
Neutral
¥1.50T17.101.09%3.50%-11.50%25.86%
65
Neutral
¥962.49B9.888.79%2.68%-1.64%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
¥558.68B77.071.08%3.37%-1.94%-84.08%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4021
Nissan Chemical
6,597.00
2,372.73
56.17%
JP:3405
Kuraray Co
1,792.50
-3.59
-0.20%
JP:4188
Mitsubishi Chemical Holdings
1,117.50
385.91
52.75%
JP:4063
Shin-Etsu Chemical Co
5,750.00
1,170.05
25.55%
JP:4005
Sumitomo Chemical Co
568.00
230.50
68.29%
JP:4042
Tosoh
2,640.00
658.44
33.23%

Nissan Chemical Corporate Events

Nissan Chemical Delivers Profit Growth and Confirms Outlook for FY2025
Feb 9, 2026

Nissan Chemical reported consolidated results for the nine months to Dec. 31, 2025, with net sales rising 11.8% year on year to ¥195.4 billion and net income attributable to owners of the parent climbing 10.5% to ¥35.0 billion, while basic earnings per share reached ¥259.10. Total assets increased to ¥340.1 billion and the equity ratio improved to 71.1%, underscoring a solid financial position supported by higher comprehensive income.

The company kept its full-year outlook unchanged, forecasting fiscal 2025 net sales of ¥272.2 billion and net income of ¥44.0 billion, alongside an annual dividend of ¥180 per share, up from ¥174 the previous year. Steady profit growth, a higher projected year-end dividend, and continued share treasury activity signal confidence in earnings resilience and a commitment to shareholder returns, which may strengthen its standing among institutional investors and analysts.

The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6086.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.

Nissan Chemical Finalizes Share Buyback Tranche
Feb 4, 2026

Nissan Chemical completed a board-authorized share repurchase program by acquiring 26,400 shares for ¥144.2 million between February 1 and February 3, 2026 on the Tokyo Stock Exchange. The buyback brings cumulative purchases under the May 2025 mandate to 1,815,100 shares for ¥8.999 billion, signaling continued capital allocation toward shareholder returns before the March 31, 2026 deadline.

The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6086.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.

Nissan Chemical Nears Completion of Share Buyback Program
Feb 3, 2026

Nissan Chemical Corporation has continued its share buyback program, repurchasing 380,000 common shares on the Tokyo Stock Exchange between January 1 and January 31, 2026, at a total cost of approximately 2.06 billion yen. This transaction forms part of a broader board-approved repurchase authorization from May 2025 allowing buybacks of up to 2.5 million shares or 9 billion yen through March 31, 2026; as of January 31, 2026, the company has acquired 1,788,700 shares for about 8.86 billion yen, indicating the program is close to completion and reflecting ongoing efforts to enhance shareholder returns and optimize capital structure.

The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6086.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.

Nissan Chemical Progresses Share Buyback Program, Repurchasing 340,000 Shares in December
Jan 6, 2026

Nissan Chemical Corporation has continued its share repurchase program, buying 340,000 common shares on the Tokyo Stock Exchange between December 1 and December 31, 2025, at a total cost of approximately 1.8 billion yen. This transaction forms part of a broader board-approved buyback plan, under which the company is authorized to repurchase up to 2.5 million shares or 9 billion yen through March 31, 2026; as of December 31, 2025, it had cumulatively acquired about 1.41 million shares for roughly 6.8 billion yen, signaling an ongoing effort to enhance capital efficiency and return value to shareholders.

The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6081.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 11, 2026